Back to News

Covid Vaccine Posted on 8 Dec 2020

 

Coronavirus vaccin

A coronavirus (COVID-19) vaccine developed by Pfizer/BioNTech has been approved for use in the UK.

 

Pfizer/BioNTech vaccine is expected to be made available from 7th December 2020.

 

The vaccine has met strict standards of safety, quality and effectiveness set out by the independent Medicines and Healthcare products Regulatory Agency (MHRA).

 

Other vaccines are being developed. They will only be available on the NHS once they have been thoroughly tested to make sure they are safe and effective.

 

Vaccine safety

 

Any coronavirus vaccine that is approved must go through all the clinical trials and safety checks all other licensed medicines go through. The UK has some of the highest safety standards in the world.

 

Vaccines will only be used if they are approved by the MHRA. The MHRA has been monitoring every stage of coronavirus vaccine development.  So far, thousands of people have been given a coronavirus vaccine and no serious side effects or complications have been reported.

 

Who will get the vaccine

 

The NHS will start giving the coronavirus vaccine as soon as it is available. 

 

You will be contacted when it's your turn.

 

At first, the vaccine will be offered to people who are most at risk from coronavirus, before being offered more widely.

 

We expect the vaccine will first be offered to:

 

    • people who live in care homes and care home workers

    • people aged 80 and over

    • health and social care workers in England

 

The final decision on who will get the vaccine first will follow advice from the Joint Committee on Vaccination and Immunisation (JCVI).

 

 

 

Read the latest JCVI advice on priority groups for the COVID-19 vaccination on GOV.UK

 

 

 

Coronavirus (COVID-19) vaccine - NHS (www.nhs.uk)

 

 

 

  • Non Housebound Over 80+                         

  • Non Housebound Over 75s

  • Non Housebound Over 70s

  • Non Housebound Over 65s

  • High & Moderate Risk Under 65s

    The risk groups identified are set out below:

        • chronic respiratory disease, including chronic obstructive pulmonary disease (COPD), cystic fibrosis and severe asthma

        • chronic heart disease (and vascular disease)

        • chronic kidney disease

        • chronic liver disease

        • chronic neurological disease including epilepsy

        • Down’s syndrome

        • severe and profound learning disability

        • diabetes

        • solid organ, bone marrow and stem cell transplant recipients

        • people with specific cancers

        • immunosuppression due to disease or treatment

        • asplenia and splenic dysfunction

        • morbid obesity

        • severe mental illness

  • Non Housebound Over 60s

  • Non Housebound Over 55s

  • Non Housebound Over 50s

 

Share